Medicaid expansion significantly increases buprenorphine prescriptions for opioid treatment, highlighting insurance's role in addressing the opioid crisis and ensuring access to addiction medication.

Explore the implications of the 2025 decision on ACA enhanced tax credits that impacts health insurance affordability for 24 million Americans and federal health policy.

Colorado mandates insurers to revise 2026 individual market rates factoring in new state funding amid federal subsidy expiration risks, moderating premium hikes.

CMS will not approve new Medicaid 1115 waivers for workforce initiatives, shifting federal support away from addressing provider shortages via these programs. This change affects state capacity to invest in Medicaid workforce development.

An in-depth analysis of 2024 U.S. healthcare policy updates affecting Medicaid, Medicare payments, telehealth, and administrative reforms impacting medical groups and physicians.

Iowa insurance market braces for premium hikes as COVID-era ACA enhanced premium tax credits are set to expire in 2025, driving coverage affordability concerns and regulatory actions.

New Hampshire's House Bill 507 shortens mental health provider credentialing to 30 days for private insurers, aiming to reduce care delays. Challenges in enforcement and insurer compliance remain.

Study finds hospital involvement in Medicare ACOs does not significantly change emergency department admission rates, length of stay, or costs, suggesting current ACO models have limited impact on acute care spending.

Explore Medicare coverage limitations for Saxenda, a GLP-1 agonist approved for weight loss, and the implications for obesity drug access and insurance plan strategies.

Medicare Part D enrollees may face significant premium hikes up to $50 monthly in 2025 due to increased drug spending, policy changes, and reduced federal stabilization funding. Compare plans during open enrollment.